Acclinate Logo
Talk to Our Team

Birmingham, AL ( April 18, 2022) - Acclinate, a leading digital health company, announced the appointment of Camille Pope, PharmD as Chief Medical Lead. She brings 14+ years of pharmaceutical industry experience to the company. In this role, Camille will oversee all medical and scientific communication between community members and pharmaceutical industry/healthcare partners. She will also contribute strategic market intelligence to help further develop Acclinate’s platform and services.  

“Acclinate has made great strides in building a world-class team and developing innovative technologies to drive sustained community engagement leading to greater clinical trial diversity," said Dr. Pope. "I'm thrilled to join the Acclinate team and work with such a talented group of individuals on our quest to achieve health equity through inclusive research".

With experience in medical affairs across several therapeutic areas, Camille is a proven pharmaceutical industry leader with extensive drug launch experience. Before joining Acclinate, Camille served as the US Medical Lead for Prostate Cancer at AstraZeneca and as a Senior MedicalScience Liaison for Hepatitis C & HIV at Abbvie. She was recognized for her leadership by AstraZeneca's Rising Leaders Program and the She-Suite BrandLeadership Institute.

"Camille is a key leadership addition to our team," said Del Smith, CEO and co-founder of Acclinate. "Her extensive domain knowledge and demonstrated passion for health equity will be a tremendous asset as we continue to scale."

As an experienced healthcare professional with demonstrated expertise in diversity and inclusion, Camille is enthusiastic about fostering diverse talent and striving for health equity. She has championed several projects to address clinical trial diversity gaps and established  AstraZeneca's US Medical Oncology Inclusion& Diversity Talent Recruitment Workstream, which led to new partnerships with Howard University’s College of Pharmacy and the Tom Joyner Foundation.

"Acclinate continues to break down barriers for communities of color in the clinical trial space and create a more robust and efficient process for researchers and sponsors," said CDO and co-founder Tiffany Whitlow. "Leading the charge in diversifying clinical trials requires a top-tier team that exhibits leadership. I look forward to working with Camille to implement innovative strategies that will help us scale and enhance our offering.

Camille holds a Doctor of Pharmacy degree from Florida Agricultural and Mechanical University. She completed a Post-Doctoral Medical Strategy Fellowship with Bristol-Myers Squibb/Rutgers Institute for Pharmaceutical Industry Fellowships. Camille is currently earning her graduate certificate in Health Disparities Research from the University of Illinois Chicago.

_____________

About Acclinate™

Acclinate™ is a Birmingham-based digital health company helping pharmaceutical companies and healthcare organizations access and engage communities of color so that research is more inclusive.

Recent Posts

Reduce Recruitment Risk in Pharma Through Representation
4 Min Read

Key Takeaways and Learnings Underrepresentation slows recruitment, increases dropout risk, and weakens data reliability. Proactive inclusion strategie...

Read More
Beyond Compliance: Building Trust Through Robust Data Security and Ethical Practices
3 Min Read

In clinical research, data is everything. It’s the foundation of scientific discovery, the evidence behind regulatory approvals, and the key to develo...

Read More
How to Reach Diverse Patients for Clinical Trials—and Engage Them
5 Min Read

Key Takeaways and Learnings Traditional “one-size-fits-all” recruitment fails to address the barriers and concerns of underrepresented communities. Or...

Read More
What FDA Diversity Guidance Means for Your Next Trial
3 Min Read

Key Takeaways and Learnings Over the past few years, FDA diversity guidance has recommended early, structured inclusion planning. Despite shifting pol...

Read More
Beyond the Transaction: Why True Community Engagement Is the Key to Health Equity
3 Min Read

In healthcare, we often hear terms like community outreach and community engagement used interchangeably. They sound similar—both involve connecting w...

Read More
Building Trust in Clinical Trials Must Start Long Before Recruitment
4 Min Read

Key Takeaways and Learnings Building trust in clinical trials requires early, sustained community engagement—not just recruitment outreach. Historical...

Read More
Assessing Health Equity Solutions
3 Min Read

Key Takeaways and Learnings Health equity solutions must be rooted in community-informed design, not top-down assumptions. Building trust requires ong...

Read More
patient and doctor talking
5 Min Read

Key Takeaways and Learnings The recent FDA diversity in clinical trials guidance emphasizes how sponsors plan on reaching specific representation goal...

Read More
Pharmaceutical Diversity Partners Deserve More Than Performative Inclusion
3 Min Read

Key Takeaways and Learnings Representation is so much more than just showing up. Performative inclusion weakens trust and risks perpetuating dispariti...

Read More